MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients

The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as multiple sclerosis (MS). Specifically, the use of vitamin D3 for the generation of tolDC (vitD3-tolDC) constitutes one of the most widely studied...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Navarro-Barriuso, Juan, Mansilla, María José, Quirant-Sánchez, Bibiana, Ardiaca-Martínez, Alicia, Teniente-Serra, Aina, Presas-Rodríguez, Silvia, ten Brinke, Anja, Ramo-Tello, Cristina, Martínez-Cáceres, Eva M.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598738/
https://ncbi.nlm.nih.gov/pubmed/31293564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.01251
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars